May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Inhibition of Nitric Oxide Synthetase Reduces Photoreceptor Damage Caused by Photodynamic Therapy in a Model of Choroidal Neovascularization
Author Affiliations & Notes
  • H. She
    Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA
  • T. Nakazawa
    Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA
  • A. Matsubara
    Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA
  • T. Hisatomi
    Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA
  • A. Hafezi–Moghadam
    Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA
  • E.S. Gragoudas
    Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA
  • J.W. Miller
    Angiogenesis Laboratory, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA
  • Footnotes
    Commercial Relationships  H. She, None; T. Nakazawa, None; A. Matsubara, None; T. Hisatomi, None; A. Hafezi–Moghadam, None; E.S. Gragoudas, None; J.W. Miller, None.
  • Footnotes
    Support  P30 EY014104 HIGHWIRE EXLINK_ID="47:5:4570:1" VALUE="EY014104" TYPEGUESS="GEN" /HIGHWIRE , NIAID K08 A150775–02
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4570. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. She, T. Nakazawa, A. Matsubara, T. Hisatomi, A. Hafezi–Moghadam, E.S. Gragoudas, J.W. Miller; Inhibition of Nitric Oxide Synthetase Reduces Photoreceptor Damage Caused by Photodynamic Therapy in a Model of Choroidal Neovascularization . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4570.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the role of nitric oxide synthetase (NOS) in photoreceptor degeneration associated with photodynamic therapy (PDT) in a laser–induced model of choroidal neovascularization (CNV).

Methods: : CNV was induced in the eyes of adult Brown–Norway rats using laser (532nm, 150mW, 100µm, 100ms). Two weeks after laser injury, PDT (689nm, 600mW/cm2, 25J/cm2, verteporfin 6mg/m2) was performed. At 6, 24, and 48h after PDT, animals were sacrificed and photoreceptor apoptosis was quantified by TdT–dUTP terminal nick–end labeling (TUNEL). To investigate the effect of NOS inhibition on PDT–induced photoreceptor apoptosis, a single dose of the NOS inhibitor N–Nitro–L–arginine methyl ester (L–NAME, 60mg/kg) or saline was injected intraperitoneally 1h before PDT. Animals were sacrificed 24h after PDT and photoreceptor apoptosis was evaluated by TUNEL.

Results: : Two weeks after laser injury, very few TUNEL (+) cells were detected in the outer nuclear layer (ONL) or in the CNV. After PDT, TUNEL (+) cells were detected both in the CNV and in the ONL of the retina overlying the CNV. The peak of photoreceptor degeneration occurred at 24h after PDT. However, 24 h after PDT, significantly fewer TUNEL (+) cells were found in the ONL of lesions of the L–NAME treated animals (0.7±1.1, n=16 lesions) when compared to those of the saline treated animals (13.9±8.4, n=11 lesions, p< 0.05).

Conclusions: : Our preliminary data suggest that NOS inhibition may reduce PDT–induced photoreceptor degeneration in an experimental model of CNV in rats. Adjunctive NOS inhibition may have neuroprotective benefits in reducing photoreceptor injury after PDT.

Keywords: photodynamic therapy • apoptosis/cell death • photoreceptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×